Manufacturer
Dabur India Limited
8 drugs, 9 product strengths, 14 recalls on record.
Drugs Dabur India Limited makes
Menthol+1.6%Generic · 335 makersPharmacies pay from$1.0243 open recallsSodium fluoride-0.4%Generic · 150 makersPharmacies pay from$2.19Petrolatum+0.1%Generic · 123 makersPharmacies pay from$2.6110 open recallsClotrimazole+0.4%Generic · 113 makersPharmacies pay from$3.556 open recallsBacitracin / neomycin / polymyxin B+2.1%Generic · 113 makersPharmacies pay from$3.17Zinc oxide+5.3%Generic · 100 makersPharmacies pay from$3.837 open recallsMonofluorophosphateGeneric · 66 makersNo weekly price2 open recallsCamphor / Eucalyptus oil / mentholNo changeGeneric · 61 makersPharmacies pay from$2.64
Recalls
Class IIOngoingJun 24, 2026Lucky Super SoftCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0629-2026Class IIOngoingJun 24, 2026Lucky Super SoftCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0630-2026Class IIOngoingJun 24, 2026Circle KCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0631-2026Class IIOngoingJun 24, 2026Lil Drug StoreCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0632-2026Class IIOngoingJun 24, 2026Rapidol, Triple Antibiotic First Aid OintmentCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0633-2026Class IIOngoingJun 24, 2026Cura HongosCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0634-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0635-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0636-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0637-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0638-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0639-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0640-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0641-2026Class IIOngoingJun 24, 2026Med PrideCGMP Deviations; deficiencies observed during FDA inspectionDabur India Limited · D-0642-2026
About Dabur India Limited
No comments yet. Questions, tips, what worked for you - start the conversation.